Importance of circulating adipocytokines in multiple myeloma: a systematic review and meta-analysis based on case-control studies - PubMed
- ️Sat Jan 01 2022
Meta-Analysis
Importance of circulating adipocytokines in multiple myeloma: a systematic review and meta-analysis based on case-control studies
Rui Liu et al. BMC Endocr Disord. 2022.
Abstract
Background: Adipocytes and their products, adipocytokines, play important roles in the generation and development of multiple myeloma (MM). Studies have demonstrated some adipocytokines to be associated with MM, although those results are controversial. Therefore, we conducted a meta-analysis to verify the association of adipocytokines with MM.
Methods: We performed a systematic retrieval of literature published prior to 26 October 2021. Standardized mean difference (SMD) with a 95% confidence interval (CI) was calculated to evaluate pooled effects. Subgroup analysis and meta-regression analysis were conducted to detect sources of heterogeneity. Sensitivity analysis was performed to evaluate the stability of the study. Publication bias was assessed by funnel plots and Egger's linear regression test.
Results: Ten eligible studies with 1269 MM patients and 2158 controls were included. The pooled analyses indicated that circulating leptin levels of MM patients were significantly higher than control levels (SMD= 0.87, 95%CI: 0.33 to 1.41), while the circulating adiponectin levels in MM patients were significantly lower than controls with a pooled SMD of -0.49 (95%CI: -0.78 to -0.20). The difference of circulating resistin levels were not significant between MM patients and controls (SMD= -0.08, 95%CI: -0.55 to 0.39). Subgroup analysis and meta-regression analysis found that sample size, age, and sex were possible sources of heterogeneity. Sensitivity analysis demonstrated our pooled results to be stable.
Conclusion: Decreased circulating adiponectin and increased leptin levels were associated with the occurrence and development of MM. Adiponectin and leptin may be potential biomarkers and therapeutic targets for MM.
Keywords: Adiponectin; Leptin; Meta-analysis; Multiple myeloma; Resistin.
© 2022. The Author(s).
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
![Fig. 1](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/420d/8787905/da155c6c597e/12902_2022_939_Fig1_HTML.gif)
Flow diagram of the selection process for the meta-analysis
![Fig. 2](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/420d/8787905/b3c88239668e/12902_2022_939_Fig2_HTML.gif)
Forest plots of SMD with 95% CI of circulating leptin (A), adiponectin (B) and resistin (C) levels between MM patients and controls
![Fig. 3](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/420d/8787905/4e209f9f4224/12902_2022_939_Fig3_HTML.gif)
Forest plots of subgroup analysis by BMI (A), age (B) and case (C) in leptin
![Fig. 4](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/420d/8787905/51dcd9b66bad/12902_2022_939_Fig4_HTML.gif)
Forest plots of subgroup analysis by race (A) and age (B) in adiponectin
![Fig. 5](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/420d/8787905/2a11744e6b81/12902_2022_939_Fig5_HTML.gif)
The pooled SMD and 95%CI of eligible studies of leptin and adiponectin through sensitivity analysis
Similar articles
-
Yang J, Zhang X, Ma Y, Wu M, Hu X, Han R, Yuan Y, Wang M, Chen M, Jiang S, Tong J, Xu S, Xu J, Shuai Z, Zou Y, Pan F. Yang J, et al. Int Immunopharmacol. 2017 Nov;52:310-317. doi: 10.1016/j.intimp.2017.09.029. Epub 2017 Oct 3. Int Immunopharmacol. 2017. PMID: 28985620 Review.
-
Meta-analysis of circulating adiponectin, leptin, and resistin levels in systemic sclerosis.
Lee YH, Song GG. Lee YH, et al. Z Rheumatol. 2017 Nov;76(9):789-797. doi: 10.1007/s00393-016-0172-5. Z Rheumatol. 2017. PMID: 27515182 English.
-
Rodríguez AJ, Nunes Vdos S, Mastronardi CA, Neeman T, Paz-Filho GJ. Rodríguez AJ, et al. J Diabetes Complications. 2016 Mar;30(2):357-67. doi: 10.1016/j.jdiacomp.2015.11.004. Epub 2015 Nov 7. J Diabetes Complications. 2016. PMID: 26684169 Review.
-
Crider K, Williams J, Qi YP, Gutman J, Yeung L, Mai C, Finkelstain J, Mehta S, Pons-Duran C, Menéndez C, Moraleda C, Rogers L, Daniels K, Green P. Crider K, et al. Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
Lee YH, Song GG. Lee YH, et al. Clin Exp Dermatol. 2018 Jul;43(5):536-545. doi: 10.1111/ced.13383. Epub 2018 Jan 22. Clin Exp Dermatol. 2018. PMID: 29356069 Review.
Cited by
-
Obesity as a risk factor for multiple myeloma: insight on the role of adipokines.
Tie W, Ma T, Yi Z, Liu J, Li Y, Bai J, Li L, Zhang L. Tie W, et al. Pathol Oncol Res. 2023 Aug 10;29:1611338. doi: 10.3389/pore.2023.1611338. eCollection 2023. Pathol Oncol Res. 2023. PMID: 37637774 Free PMC article. Review.
-
Bradey AL, Fitter S, Duggan J, Wilczek V, Williams CMD, Cheney EA, Noll JE, Tangseefa P, Panagopoulos V, Zannettino ACW. Bradey AL, et al. Sci Rep. 2022 Jul 30;12(1):13128. doi: 10.1038/s41598-022-17403-9. Sci Rep. 2022. PMID: 35908046 Free PMC article.
-
Body size and risk of multiple myeloma in the Black Women's Health Study.
Kataria Y, Niharika Pillalamarri B, Zirpoli G, Szalat R, Palmer JR, Bertrand KA. Kataria Y, et al. Br J Cancer. 2024 Mar;130(5):830-835. doi: 10.1038/s41416-023-02571-w. Epub 2024 Jan 12. Br J Cancer. 2024. PMID: 38212484 Free PMC article.
References
-
- Siegel RL, Miller KD, Goding Sauer A, Fedewa SA, Butterly LF, Anderson JC, Cercek A, Smith RA, Jemal A. Colorectal cancer statistics, 2020. CA Cancer J Clin. 2020;70(3):145–164. - PubMed
-
- Abar L, Sobiecki JG, Cariolou M, Nanu N, Vieira AR, Stevens C, Aune D, Greenwood DC, Chan DSM, Norat T. Body size and obesity during adulthood, and risk of lympho-haematopoietic cancers: an update of the WCRF-AICR systematic review of published prospective studies. Ann Oncol. 2019;30(4):528–541. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical